Fentanyl and Nalbuphine: Interaction Details
- Fentanyl
- AbstralActiqFentora +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl and Nalbuphine interaction:
Fentanyl
- Abstral
- Actiq
- Fentora
- Onsolis
- Subsys
- Ionsys
Nalbuphine
We don't have a drug information page for Nalbuphine yet. Have a question about Nalbuphine? Ask a pharmacist, free →
What Happens When You Take Fentanyl With Nalbuphine
What can happen when they are taken together (rated Major)
Reduced analgesic effect or precipitation of withdrawal symptoms, an increased risk of and an increased risk of profound , , , coma and death
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
of fentaNYL with a depressant that is a mixed / or a partial agonist opioid analgesic should be avoided. The combination can produce CNS and serotonergic effects, leading to respiratory depression, hypotension, profound sedation, coma, or death, and it may also lessen the analgesic effect of fentaNYL and/or trigger withdrawal symptoms.
The combination should be kept for patients whose alternative treatment options are inadequate. When the drugs must be given together, use the lowest effective dosages for the shortest necessary duration of co-administration, and titrate doses according to clinical response.
Patients and caregivers should be informed about, and educated to recognize, the signs and symptoms of respiratory depression. Serotonin syndrome can be fatal, and its symptoms may include mental status changes, autonomic instability, neuromuscular abnormalities, and/or symptoms.
Symptoms usually begin within several hours to a few days after the drugs are started together, though onset can be later. Patients should be monitored for respiratory depression, sedation, hypotension, and serotonin syndrome, and fentaNYL should be stopped if serotonin syndrome is suspected.21 When fentaNYL injection is used for postoperative analgesia, begin with a reduced dose, and have fluids and other measures on hand to manage possible hypotension.3
The Fentanyl and Nalbuphine Interaction, Explained
Fentanyl and nalbuphine are both strong pain medicines, and using them together can be risky. Nalbuphine partly blocks opioid receptors while also activating them, so it can make fentanyl work less well for pain and can even trigger withdrawal symptoms (like sweating, restlessness, or body aches). Together they can also add up to extra sleepiness, slow or shallow breathing, low blood pressure, and in serious cases coma. The record also notes a risk of (agitation, confusion, fast heartbeat, shaking, diarrhea).
Please don't change either medicine on your own. Your care team can sometimes use the combination carefully, with low doses and close watching. Tell them right away about unusual drowsiness, trouble breathing, or confusion.
Fentanyl (full mu ) plus nalbuphine (mixed kappa agonist/mu or partial agonist). is to be avoided and reserved for patients without adequate alternatives.
- Mechanism: competitive mu-receptor by nalbuphine (reduced fentanyl analgesia, possible precipitated withdrawal in -dependent patients); ; additive .
- Risks: , profound , , coma, death; .
- Onset: unspecified; serotonin syndrome typically within hours to days, but may be later.
- Evidence: probable.
- Management: lowest effective doses for the shortest duration, titrate to response, monitor for respiratory depression, sedation, hypotension, and toxicity. Discontinue fentanyl if serotonin syndrome is suspected. For postoperative analgesia, start with a lower fentanyl injection dose and have fluids available for hypotension. Educate patients and caregivers.
See the 8 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl and Nalbuphine Interact
The likely mechanism
receptor ; ; additive
How to Manage the Fentanyl and Nalbuphine Interaction
Your care team will usually try to avoid this combination and use it only when other options aren't enough. If both are needed, they typically use the lowest effective doses for the shortest time, adjust doses based on how you respond, and may monitor you more closely.
- Keep taking both exactly as prescribed unless your team tells you otherwise.
- Ask your pharmacist or prescriber to review your pain plan.
- Make sure you and your caregivers know the signs of slowed breathing and (confusion, agitation, shaking, fast heartbeat, diarrhea).
- Seek urgent help if these occur.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl or Nalbuphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
6 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection
Observational studies have shown that using analgesics together with raises the risk of drug-related death relative to opioid analgesic use alone. Since other depressant drugs share similar pharmacological properties, a comparable risk can reasonably be expected when they are used concomitantly with opioid analgesics.321
-
Report 2 · Study title
Case scenario: opioid association with serotonin syndrome: implications to the practitioners
A case report describes -associated in a 58-year-old man with chronic back pain. He had been stable on treatment for pain and depression, with a regimen of transdermal fentaNYL 75 mcg/hr patches, oxyCODONE 5 mg/acetaminophen 325 mg twice daily, celecoxib 200 mg twice daily, citalopram 40 mg once daily, and mirtazapine 50 mg at night.
He also took doxazosin 4 mg daily and zolpidem 12.5 mg as needed for insomnia. Because he reported inadequate pain control, the fentaNYL regimen was changed so that the patch was replaced every 2 days instead of every 3 days.
About 1 week after this increase, he reported anxiety, tremulousness, fever, and sweating. CloNIDine 0.2 mg every 4 hours was started without any improvement.
Symptoms persisted, and the next day he was given haloperidol and LORazepam for anxiety and agitation. He stopped using his fentaNYL patch and, 2 days later, presented to the emergency room with opiate withdrawal.
He was then diagnosed with serotonin syndrome, even though the fentaNYL patch had been discontinued for 30 hours. Haloperidol, fentaNYL, oxyCODONE/acetaminophen, citalopram, and mirtazapine were stopped immediately, and symptoms resolved completely by the following day. Morphine sulfate was prescribed in place of fentaNYL, and citalopram and mirtazapine were restarted, with no recurrence of serotoninergic symptoms at follow-up.4
-
Report 3 · Study title
Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy
associated with fentaNYL use during an esophagogastroduodenoscopy was reported in a 39-year-old woman who was also taking sertraline 100 mg daily as an outpatient. She first presented with hematemesis and had a history of alcoholic cirrhosis.
Before the procedure, an octreotide and pantoprazole drip was begun, and 2 doses of fentaNYL 50 micrograms and 2 doses of midazolam 1 mg were given. After the procedure she became somnolent and extremely rigid in all four extremities, and vecuronium and etomidate were administered for immediate intubation.
The rigidity progressed, with diffuse diaphoresis, horizontal roving eye movements, and a fever of 105 degrees F. Because of the possibility of seizure activity, LORazepam 2 mg IV was given without improvement, and a propofol drip was started for continued during intubation.
A CPK of 2800 units/L and an ammonia level of 340 micromols/L pointed to . A CT scan of the brain excluded an acute intracranial process, and the neurology team diagnosed serotonin syndrome secondary to an interaction between fentaNYL and sertraline.
Propofol was continued for sedation, and she received supportive treatment with a cooling blanket and cyproheptadine. After 3 days her temperature and CPK normalized, and she was later extubated with no further complications.5
-
Report 4 · Study title
Serotonin syndrome precipitated by fentanyl during procedural sedation
after IV fentaNYL administration during surgical procedures was reported in 2 patients who were also taking (sertraline and escitalopram). The first patient received IV fentaNYL (50 mcg), midazolam (2 mg), and 2 doses of propofol (60 mg and 40 mg) at an outpatient surgery center before a carpal tunnel release.
After surgery she began shivering and grew increasingly agitated, and she was transferred to the emergency department. On presentation she was combative, diaphoretic, confused, unable to follow commands, tachycardic, and hypertensive, with hyperreflexia and ankle clonus.
Creatinine kinase, at baseline, rose to 613 units/L on hospital day 2. The toxicology service treated her with escalating doses of without improvement.
She was then intubated and sedated with a continuous propofol infusion. She was extubated after 2 days, all symptoms had resolved by day 3, and she was discharged home.
The second patient was a 59-year-old woman admitted for an omentectomy, during which she received IV fentaNYL 250 micrograms, etomidate, vecuronium, morphine, and cephazolin. After extubation she became hypoxic and acidotic and was reintubated and moved to the ICU.
On postoperative day 1 she was extubated, and she later became tachycardic and unable to follow commands. On examination she was agitated and diaphoretic, with patellar hyperreflexia and bilateral 3 to 4 beat ankle clonus.
Laboratory evaluation showed a peak creatine kinase of 1161 units/L on postoperative day 2. She was treated with LORazepam and cyproheptadine, and symptoms resolved after 3 days.6
-
Report 5 · Study title
Serotonin toxicity caused by an interaction between fentanyl and paroxetine
A case of postoperative after fentaNYL use for general anesthesia and postoperative analgesia was reported in a 60-year-old woman who was also receiving PARoxetine. Her outpatient medications were only PARoxetine and thyroxine, for depression and hypothyroidism.
She was admitted for extensive resection of a recurrent left chest wall myxofibrosarcoma and received propofol and 200 mcg of fentaNYL to induce anesthesia. She also received a further 800 mcg of fentaNYL intraoperatively (intermittent 50 mcg boluses) and then a fentaNYL infusion (100 to 200 mcg/hr) for postoperative and analgesia (2545 mcg of fentaNYL in total over 36 hours).
The infusion was continued for 36 hours after surgery, at which point neurological examination showed intermittent agitation, bilateral hypertonia and hyperreflexia, and bilateral inducible ankle clonus. Symptoms were more severe in the lower limbs and on the right side of the body.
A CT scan of the brain was unremarkable, and all other findings, including thyroid function testing, were within normal limits except for elevated blood pressure (180/90 mmHg), which resolved spontaneously 24 hours after the procedure. fentaNYL was discontinued, and 24 hours later neurological symptoms had markedly improved, with complete recovery by postoperative day 4. She was ultimately discharged home without further complications.7
-
Report 6 · Study title
Serotonin syndrome caused by interaction between citalopram and fentanyl
A 65-year-old woman treated with citalopram for depression developed after a fentaNYL patch was started. She had recently been diagnosed with myelodysplastic/myeloproliferative disease, and her regular medications included RABEprazole, tolterodine, HYDROcodone, and over-the-counter .
She was hospitalized with abdominal pain and worsening back pain, and a spontaneous retroperitoneal was found. During hospitalization, the worsening back pain was treated with a fentaNYL transdermal patch (25 mcg/hr).
Within 24 hours of starting fentaNYL, she progressively developed increasing confusion, agitation, combativeness, upper extremity tremors, myoclonic jerks, hyperreflexia, and unsteady gait, consistent with serotonin syndrome. (110 to 120 beats per minute) was also observed.
A CT scan and laboratory values showed no abnormalities. fentaNYL was discontinued, and all symptoms resolved within 24 to 36 hours. Symptoms did not recur when oxyCODONE was started for the back pain. Based on the Naranjo adverse event probability scale, the association between this serotonin syndrome and the of fentaNYL and citalopram was judged probable.8
Fentanyl and Nalbuphine: Common Questions
How serious is the Fentanyl and Nalbuphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl and Nalbuphine interaction managed?
Your care team will usually try to avoid this combination and use it only when other options aren't enough. If both are needed, they typically use the lowest effective doses for the shortest time, adjust doses based on how you respond, and may monitor you more closely. Keep taking both exactly as prescribed unless your team tells you otherwise. Ask your pharmacist or prescriber to review your pain… Management is individual — always follow your own care team's guidance.
Is there an alternative to taking Fentanyl with Nalbuphine?
The interaction record says a different medicine may be considered in place of one of these two.
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fentanyl and Nalbuphine Interaction
Ask in your own words about taking Fentanyl and Nalbuphine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (8)
- Product Information: FENTORA® buccal tablets, fentanyl citrate buccal tablets. Teva Pharmaceuticals USA Inc (per FDA), Parsippany, NJ, 2025.
- Product Information: ACTIQ® oral transmucosal lozenge, fentanyl citrate oral transmucosal lozenge. Teva Pharmaceuticals USA, Inc. (per FDA), Parsippany, NJ, 2025. DailyMed
- Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Rising Pharma Holdings, Inc. (per FDA), East Brunswick, NJ, 2025. DailyMed
- Rastogi R, Swarm RA, & Patel TA: Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiology 2011; 115(6):1291-1298. PubMed
- Alkhatib AA, Peterson KA, & Tuteja AK: Serotonin syndrome as a complication of fentanyl sedation during esophagogastroduodenoscopy. Dig Dis Sci 2010; 55(1):215-216. PubMed
- Kirschner R & Donovan JW: Serotonin syndrome precipitated by fentanyl during procedural sedation. J Emerg Med 2010; 38(4):477-480. DOI
- Rang ST, Field J, & Irving C: Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth 2008; 55(8):521-525. PubMed
- Ailawadhi S, Sung KW, Carlson LA, et al: Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 2007; 32(2):199-202. PubMed
Other Serious Interactions of Fentanyl and Nalbuphine
Also serious with Fentanyl
- IsocarboxazidContraindicated
- LevoketoconazoleContraindicated
- NaltrexoneContraindicated
- PhenelzineContraindicated
Also serious with Nalbuphine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Fentanyl
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- + 222 more
With Nalbuphine
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- L-TryptophanMajor
- AshwagandhaModerate
- + 92 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.